ASEP Medical Holdings Inc.

Equities

ASEP

CA04368A1057

Biotechnology & Medical Research

Delayed Canadian Securities Exchange 11:18:02 2024-05-01 am EDT 5-day change 1st Jan Change
0.2 CAD 0.00% Intraday chart for ASEP Medical Holdings Inc. +48.15% -2.44%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Asep Medical Says Its Sepsis Diagnostic Technology Can Provide Improved Odds for Pediatric Appendicitis MT
ASEP Medical Holdings Inc. announced that it expects to receive CAD 1.5 million in funding CI
ASEP Medical Holdings Reports Settlement of Debt; Down 6.8% MT
ASEP Medical Holdings Reports Settlement of Debt MT
ASEP Medical Holdings Inc. announced that it expects to receive CAD 2 million in funding CI
ASEP Medical Holdings Granted Patent Approval for its AI-based Sepsis Diagnostic Technology in the US MT
Asep Medical Holdings Inc. is Granted Patent Approval for its AI-based Sepsis Diagnostic Technology in the US CI
ASEP Medical Holdings Signs JV Agreement with Chinese Medical Diagnostics Co Sansure Biotech Inc. MT
Asep Inc. Brief: Said Overnight Monday It Completed Submission of Registration Statement for NASDAQ Listing MT
ASEP Medical Holdings Receives $200k Grant from NanoMedicines Innovation Network Funded by the Government of Canada MT
ASEP Medical Holdings Inc. Announces Addition of Louise Rose Pacini to its Advisory Board CI
ASEP Medical Holdings Down Near 4% As Says Finalizing NASDAQ Listing MT
ASEP Medical Holdings Finalizing NASDAQ Listing MT
Asep Inc. Higher After Signing Definitive Agreement for JV with Bahrain-based Seaspring W.L.L MT
Asep Inc. Signs Definitive Agreement for Joint Venture with Bahrain-based Seaspring W.L.L. for Regulatory Approval and Commercialization of Sepsis Diagnosis Technology in the Kingdom of Bahrain, the Middle East and North Africa CI
Asep Inc. Reports "Ground-breaking" AI Technology to Rapidly Identify Severe Sepsis MT
Asep Inc. Brief: Up 30% After Announcing "Ground-breaking" A.I. Technology for Rapid Identification of Severe Sepsis and Improved Superbug Therapies MT
Asep Medical Holdings Inc. Announces Ground-Breaking A.I. Technology for Rapid Identification of Severe Sepsis and Improved Superbug Therapies CI
Asep Inc. Brief: Up Near 20% As Engages Aegis Capital Corporation for Listing on NASDAQ Stock Exchange MT
Asep Medical Holdings Inc. Announces Executive Changes CI
Asep Inc. Lower After Signing JV Term Sheet with Leading Chinese Medical Diagnostic Co. Sansure Biotech Inc. MT
ASEP Medical Holdings Inc. Signs Joint Venture Term Sheet with Sansure Biotech Inc. in Preparation for the Commercialization of the Sepset(ER) Sepsis Diagnostic Test in China CI
Asep Medical Signs LOI for JV With Bahrain Consultancy Seaspring For Commercialization of Sepsis Diagnosis Technology MT
Asep Medical Holdings Inc. Signs Letter of Intent for Joint Venture with Seaspring W.L.L. for Regulatory Approval and Commercialization of Sepsis Diagnosis Technology in the Kingdom of Bahrain, the Middle East and North Africa CI
Asep Medical Holdings Inc. Provides Update on Its Prior Disclosure Regarding Proprietary Diagnostic & Therapeutic Technologies CI
Chart ASEP Medical Holdings Inc.
More charts
ASEP Medical Holdings Inc. is a Canada-based company, which is in the business of acquiring research and development assets, technologies and/or businesses in the area of life sciences and medical diagnostics. The Company’s consolidates three development-stage companies, including Sepset Biosciences Inc., ABT Innovations Inc., and SafeCoat Medical Inc. It provides medical devices with an anti-microbial, antifouling coating through its SafeCoat Medical Inc. The Company also provides diagnostic kits for predicting the onset of severe Sepsis and organ failure through its Sepset Biosciences Inc. The Company also offers peptide technology through its ABT Innovations Inc. Its technology includes diagnostic and therapeutic. It has developed a novel diagnostic assay for the early and rapid diagnosis of sepsis, based on the detection of molecular signatures of sepsis specific to the immune response, rather than the presence of a pathogen.
More about the company
  1. Stock Market
  2. Equities
  3. ASEP Stock
  4. News ASEP Medical Holdings Inc.
  5. ASEP Medical Holdings Reports Settlement of Debt